00:00
19:29
Dr. Johannes Kratz, surgeon at Massachusetts General Hospital, reviews data supporting a method to define prognosis in early stage non-small cell lung cancer (NSCLC) based on molecular signatures and proposes a new staging system.
Dr. Johannes Kratz, surgeon at Massachusetts General Hospital, reviews data supporting a method to define prognosis in early stage non-small cell lung cancer (NSCLC) based on molecular signatures and proposes a new staging system. read more read less

10 years ago #biological, #cancer, #cancergrace, #early, #general, #grace, #gracecast, #hospital, #johannes, #kratz, #lung, #massachusetts, #mgh, #molecular, #nsclc, #pervenio, #profiling, #signature, #stage, #staging